Patients seeking novel weight loss drugs find a ‘wild west’ of online prescribers

Stat News

4 August 2022 - Briana Lawson was ready to knock her diabetes into remission. For years, the 47 year old health care consultant had treated her high blood sugar with metformin hydrochloride.

But to avoid a lifetime of medication, she knew she’d need to lose weight. She’d tried fad diets, Weight Watchers, Nutrisystem, and had even considered surgery when the results didn’t stick. 

When she started reading about GLP-1 receptor agonists — which, last year, became the first new FDA approved chronic weight management drug since 2014 — she was ready to give them a try.

Read Stat News article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Market access